ICML 2019 | Highlights of ICML 2019

L:

During ICML 2019 in Lugano, Switzerland, the Lymphoma Hub were pleased to discuss the highlights of ICML 2019 with our Chair, Gilles Salles, from South Lyon University Hospital Complex, Lyon, FR.

Gilles Salles spoke of the number of updates to studies from all over the world, and commented that unfortunately, studies investigating at the addition of lenalidomide to the R-CHOP regimen did not show significant benefits for patients.

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF